Search Results - "Moger, Tron"

Refine Results
  1. 1

    Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial by Hofvind, Solveig, Holen, Åsne S, Aase, Hildegunn S, Houssami, Nehmat, Sebuødegård, Sofie, Moger, Tron A, Haldorsen, Ingfrid S, Akslen, Lars A

    Published in The lancet oncology (01-06-2019)
    “…Digital breast tomosynthesis is an advancement of mammography, and has the potential to overcome limitations of standard digital mammography. This study aimed…”
    Get full text
    Journal Article
  2. 2

    A lean additive frailty model: With an application to clustering of melanoma in Norwegian families by Brathovde, Mari, Moger, Tron A, Aalen, Odd O, Grotmol, Tom, Veierød, Marit B, Valberg, Morten

    Published in Statistics in medicine (15-10-2023)
    “…Additive frailty models are used to model correlated survival data. However, the complexity of the models increases with cluster size to the extent that…”
    Get full text
    Journal Article
  3. 3

    Patient experiences and clinical outcomes of admissions to municipal acute wards versus a hospital: a multicentre randomised controlled trial in Norway by Nystrøm, Vivian, Lurås, Hilde, Moger, Tron, Leonardsen, Ann-Chatrin Linqvist

    “…In Norway, municipal acute wards (MAWs) were implemented as alternatives to hospitalisation. Evaluations of the quality of MAW services are lacking. The…”
    Get full text
    Journal Article
  4. 4

    Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug‐related problems by Viktil, Kirsten K., Blix, Hege S., Moger, Tron A., Reikvam, Aasmund

    Published in British journal of clinical pharmacology (01-02-2007)
    “…What is already known about this subject • Polypharmacy has been linked to heightened risk of occurrence of drug‐related problems (DRPs) and a detrimental…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Finding good alternatives to hospitalisation: a data register study in five municipal acute wards in Norway by Nystrøm, Vivian, Lurås, Hilde, Moger, Tron, Leonardsen, Ann-Chatrin Linqvist

    Published in BMC health services research (30-05-2022)
    “…In Norway, municipal acute wards (MAWs) have been implemented in primary healthcare since 2012. The MAWs were intended to offer decentralised acute medical…”
    Get full text
    Journal Article
  7. 7

    Innovations in use of registry data (INOREG): Design of a registry-based study analyzing care pathways and outcomes for chronic patients by Moger, Tron A., Amundsen, Olav, Tjerbo, Trond, Hellesø, Ragnhild, Holte, Jon Helgheim, Vøllestad, Nina

    Published in Nordic journal of health economics (21-12-2023)
    “…In recent years there have been several political initiatives in Norway, requiring more research into how multimorbidity and health care pathways in the…”
    Get full text
    Journal Article
  8. 8

    Age-Incidence Curves of Nasopharyngeal Carcinoma Worldwide: Bimodality in Low-Risk Populations and Aetiologic Implications by BRAY, Freddie, HAUGEN, Marion, MOGER, Tron A, TRETLI, Steinar, AALEN, Odd O, GROTMOL, Tom

    “…The distinct geographic variation in the global incidence of nasopharyngeal carcinoma reflects a complex etiology involving viral, environmental, and genetic…”
    Get full text
    Journal Article
  9. 9

    Cost-effectiveness of TNF inhibitors vs synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a Markov model study based on two longitudinal observational studies by Kvamme, Maria K, Lie, Elisabeth, Uhlig, Till, Moger, Tron A, Kvien, Tore K, Kristiansen, Ivar S

    Published in Rheumatology (Oxford, England) (01-07-2015)
    “…The objective of this study was to estimate the additional costs and health benefits of adding a TNF inhibitor (TNFi) (adalimumab, certolizumab, etanercept,…”
    Get full text
    Journal Article
  10. 10

    Drug safety at admission to emergency department: an innovative model for PRIOritizing patients for MEdication Reconciliation (PRIOMER) by Damlien, Lisbeth, Davidsen, Nina, Nilsen, Merethe, Godø, Aasmund, Moger, Tron A, Viktil, Kirsten K

    Published in European journal of emergency medicine (01-10-2017)
    “…OBJECTIVEThis study aimed to develop an innovative prioritizing model for conducting medication reconciliation (MR) at a fast-paced workflow emergency…”
    Get full text
    Journal Article
  11. 11

    Early assessment of innovation in a healthcare setting by Støme, Linn Nathalie, Moger, Tron, Kidholm, Kristian, Kværner, Kari J

    “…Early assessment can assist in allocating resources for innovation effectively and produce the most beneficial technology for an institution. The aim of the…”
    Get more information
    Journal Article
  12. 12

    How are drug regimen changes during hospitalisation handled after discharge: a cohort study by Viktil, Kirsten K, Blix, Hege Salvesen, Eek, Anne Katrine, Davies, Maren Nordsveen, Moger, Tron A, Reikvam, Aasmund

    Published in BMJ open (01-01-2012)
    “…Objectives To investigate drug regimen changes during hospitalisation and explore how these changes are handled after patients are transferred back into the…”
    Get full text
    Journal Article
  13. 13

    A Hierarchical Frailty Model for Familial Testicular Germ-Cell Tumors by VALBERG, Morten, GROTMOL, Tom, TRETLI, Steinar, VEIERØD, Marit B, MOGER, Tron A, AALEN, Odd O

    Published in American journal of epidemiology (15-02-2014)
    “…Using a 2-level hierarchical frailty model, we analyzed population-wide data on testicular germ-cell tumor (TGCT) status in 1,135,320 two-generational…”
    Get full text
    Journal Article
  14. 14

    Use of renal risk drugs in hospitalized patients with impaired renal function—an underestimated problem? by Blix, Hege Salvesen, Viktil, Kirsten Kilvik, Moger, Tron Anders, Reikvam, Aasmund

    Published in Nephrology, dialysis, transplantation (01-11-2006)
    “…Background. Inappropriate use of drugs in patients with renal impairment (RI) may be harmful and may have deleterious effects. We aimed to investigate the use…”
    Get full text
    Journal Article
  15. 15

    Prostate-specific antigen testing for prostate cancer: Depleting a limited pool of susceptible individuals? by Valberg, Morten, Grotmol, Tom, Tretli, Steinar, Veierød, Marit B., Moger, Tron A., Devesa, Susan S., Aalen, Odd O.

    Published in European journal of epidemiology (01-06-2017)
    “…After the introduction of the prostate specific antigen (PSA) test in the 1980s, a sharp increase in the incidence rate of prostate cancer was seen in the…”
    Get full text
    Journal Article
  16. 16

    Impact of systematic medication review in emergency department on patients’ post-discharge outcomes—A randomized controlled clinical trial by Lisbeth Damlien Nymoen, Trude Eline Flatebø, Tron Anders Moger, Erik Øie, Espen Molden, Kirsten Kilvik Viktil

    Published in PloS one (19-09-2022)
    “…Introduction The main objective of this study was to investigate whether systematic medication review conducted by clinical pharmacists can impact clinical…”
    Get full text
    Journal Article
  17. 17

    Impact of systematic medication review in emergency department on patients’ post-discharge outcomes—A randomized controlled clinical trial by Nymoen, Lisbeth Damlien, Flatebø, Trude Eline, Moger, Tron Anders, Øie, Erik, Molden, Espen, Viktil, Kirsten Kilvik

    Published in PloS one (19-09-2022)
    “…Introduction The main objective of this study was to investigate whether systematic medication review conducted by clinical pharmacists can impact clinical…”
    Get full text
    Journal Article
  18. 18

    Does the primary screening test influence women's anxiety and intention to screen for cervical cancer? A randomized survey of Norwegian women by Burger, Emily A, Nygård, Mari, Gyrd-Hansen, Dorte, Moger, Tron Anders, Kristiansen, Ivar Sonbo

    Published in BMC public health (15-04-2014)
    “…Countries must decide whether or not to replace primary cytology-based screening with primary human papillomavirus (HPV)-based screening. We aimed to assess…”
    Get full text
    Journal Article
  19. 19

    Cost structure in specialist mental healthcare: what are the main drivers of the most expensive episodes? by Ki, Yeujin, McAleavey, Andrew Athan, Moger, Tron Anders, Moltu, Christian

    “…Background Mental disorders are one of the costliest conditions to treat in Norway, and research into the costs of specialist mental healthcare are needed. The…”
    Get full text
    Journal Article
  20. 20

    Comparisons of readmissions and mortality based on post-discharge ambulatory follow-up services received by stroke patients discharged home: a register-based study by Swanson, Jayson O, Moger, Tron Anders

    Published in BMC health services research (05-01-2019)
    “…Few studies have focused on post-discharge ambulatory care for stroke patients and subsequent differences in readmission and mortality rates. Identifying…”
    Get full text
    Journal Article